Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 14;329(10):839-840.
doi: 10.1001/jama.2023.0547.

Stool-Based Screening Tests for Colorectal Cancer

Affiliations

Stool-Based Screening Tests for Colorectal Cancer

John M Carethers. JAMA. .
No abstract available

Plain language summary

A 56-year-old man with no significant medical history has declined screening colonoscopy at previous physician visits but wants to undergo a less invasive test because his father died of colorectal cancer at age 80. What would you do next?

PubMed Disclaimer

Conflict of interest statement

Dr. Carethers reports grants from the National Cancer Institute and funds from the University of Michigan during the conduct of the study. Dr. Carethers reports personal fees from Avantor, Inc., provided consultancy to Geneoscopy, Inc., and being a Board member for the American Gastroenterology Association and on the Advisory Board for the National Institute for Diabetes and Digestive and Kidney Diseases outside of the submitted work.

Similar articles

Cited by

References

    1. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Krist AH, Kubik M, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021. May 18;325(19):1965–1977. doi: 10.1001/jama.2021.6238. Erratum in: JAMA. 2021 Aug 24;326(8):773. - DOI - PubMed
    1. Carethers JM. Fecal DNA testing for colorectal cancer screening. Annu Rev Med 2020;71:59–69. - PubMed
    1. Young GP, Symonds EL, Allison JE, Cole SR, Fraser CG, Halloran SP, Kuipers EJ, Seaman HE. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci 2015;60:609–622. - PMC - PubMed
    1. Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2017;112:37–53. - PubMed
    1. Imperiale TF, Ransohoff DF, Istzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. N Eng J Med 2014;370:1287–1297. - PubMed

Publication types